Johnson Johnson (NYSE: JNJ) has proven its ability to deliver passive income growth to investors over time. The healthcare giant is a Dividend King, meaning it's increased its Dividend for more than 50 consecutive years. And, just recently, the company reiterated its commitment to boosting dividends annually. So, there's reason to be confident that an investment in J could continue to drive the value of your portfolio higher -- without you doing a thing.

All of that sounds great, but there's another reason to like J, and it has to do with a massive secret weapon that may drive earnings growth today and over the long term. That could translate into share price performance, making J a dividend and growth winner for your portfolio. The secret weapon is worth more than $13 billion, and J seized it last year, thanks to a pretty bold move.

Image source: Getty Images.

Continue reading

Source Fool.com